Charles River announced the acquisition of privately-held NewLab BioQuality AG (NewLab), a Dusseldorf, Germany-based contract service organization that provides safety and quality control services to biopharmaceutical clients. NewLab has approximately 150 employees. Both Charles River and ... mehr
Charles River Acquires NewLab BioQuality AG
Charles River announced the acquisition of privately-held NewLab BioQuality AG (NewLab), a Dusseldorf, Germany-based contract service organization that provides safety and quality control services to biopharmaceutical clients. NewLab has approximately 150 employees.
Both Charles River and NewLab provide analytical, molecular biology, virology and microbiology testing services to ensure identity, quality, stability and safety of biopharmaceuticals, and operate in full compliance with current GMP/GLP (Good Laboratory Practice) regulatory guidance. Together, Charles River and NewLab expect to provide the most comprehensive service package in the biopharmaceutical industry at a time when biologic drugs are becoming an increasing proportion of therapeutics in development.
With current operations in the United States, Scotland and Ireland, the transaction will expand Charles River's current biopharmaceutical services footprint by adding two facilities in continental Europe and will further enhance its European and Asian client base.
- Charles River
- NewLab BioQuality
- Gute Laborpraxis
Mit Wirkung zum 01. August 2005 hat die NewLab BioQuality AG (NewLab) 100% der Anteile der Firma Analysis Biomedizinische Test GmbH, Köln (Analysis) einschließlich des gesamten Personals übernommen. Der NewLab-Geschäftsbereich Virologie wird damit um wertvolle Kompetenzen und Erfahrungen er ... mehr
Die Protagen AG und Charles River Laboratories International Inc. sind eine strategische Partnerschaft eingegangen, um gemeinsam analytische Dienstleistungen von der Zelllinienentwicklung bis hin zur Batchfreigabe von Biopharmazeutika anbieten zu können. Im Rahmen des zunächst auf zwei Jahr ... mehr
As the world’s leading innovator in rapid microbial detection, Celsis ® systems are used globally by leading manufacturers in the Pharmaceutical, Home & Beauty and Dairy, Beverage & Food industries. Learn how the Celsis ® systems deliver quality assurance results in as few as 24 hours, enab ... mehrWebinarOn-Demand
Nuclear imaging provides translational and noninvasive in vivo methodology to reliably quantify pathological changes during disease progression and allows evaluation of therapeutic effects of existing or novel drugs against the disease. This webinar showcases new developments of CNS Discove ... mehrWebinarOn-Demand
High-throughput screening (HTS) is an established means to identify starting points in the drug discovery process. As a significant investment is necessary to undertake high-throughput screening efficiently, screening is increasingly being outsourced by researchers in the not-for-profit, bi ... mehr